Race/ethnicity | Studied subjects | Sample number (n) | Plasma lipids (mmol/L) | APOE genotype unaccounted for | APOE genotype accounted for | ||
---|---|---|---|---|---|---|---|
Correlation (95% CI) | p-value | Correlation (95% CI) | p-value | ||||
Whole cohort | All | 125 | t-Ch. | r = 0.228 (0.055, 0.388) | 0.010 | r (122) = 0.280 (0.110, 0.434) | 0.002 |
HDL | ρ = 0.187 (0.012, 0.351) | 0.037 | r (122) = 0.414 (0.258, 0.549) | 0.002 | |||
Controls | 53 | t-Ch. | r = 0.368 (0.108, 0.581) | 0.007 | r (50) = 0.414 (0.162, 0.615) | 0.002 | |
LDL | r = 0.285 (0.016, 0.516) | 0.038 | r (50) = 0.313 (0.047, 0.538) | 0.024 | |||
AD | 24 | HDL | r = 0.506 (0.129, 0.755) | 0.012 | r (21) = 0.555 (0.195, 0.783) | 0.006 | |
LDL/HDL | r = − 0.460 (− 0.728, − 0.070) | 0.024 | r (21) = − 0.454 (− 0.725, − 0.062) | 0.029 | |||
B/AAs | All | 58 | t-Ch. | ρ = 0.352 (0.104, 0.559) | 0.007 | r (55) = 0.367 (0.121. 0.571) | 0.005 |
LDL | ρ = 0.327 (0.076, 0.539) | 0.012 | r (55) = 0.341 (0.091, 0.550) | 0.009 | |||
Controls | 25 | t-Ch. | r = 0.456 (0.074, 0.721) | 0.022 | r (22) = 0.526 (0.165, 0.763) | 0.008 | |
LDL | r = 0.414 (0.023, 0.695) | 0.040 | r (22) = 0.464 (0.084, 0.726) | 0.022 | |||
AD | 9 | t-Ch. | r = 0.671 (0.012, 0.924) | 0.048 | r (6) = 0.584 (− 0.131, 0.899) | 0.128 | |
NHWs | All | 67 | HDL | ρ = 0.269 (0.031, 0.478) | 0.027 | r (64) = 0.263 (0.025, 0.473) | 0.033 |
AD | 15 | LDL/HDL | r = − 0.562 (− 0.834, − 0.070) | 0.029 | r (12) = − 0.462 (− 0.788, 0.066) | 0.097 |